نتایج جستجو برای: peg nanocarrier

تعداد نتایج: 17468  

2018
Raihana Rosman Bullo Saifullah Sandra Maniam Dena Dorniani Mohd Zobir Hussein Sharida Fakurazi

Lung cancer, breast cancer and colorectal cancer are the most prevalent fatal types of cancers globally. Gallic acid (3,4,5-trihydroxybenzoic acid) is a bioactive compound found in plants and foods, such as white tea, witch hazel and it has been reported to possess anticancer, antioxidant and anti-inflammatory properties. In this study we have redesigned our previously reported anticancer nanoc...

2013
Hui Zhao Hua Lu Tao Gong Zhirong Zhang

BACKGROUND Intravenous injection of lycobetaine was found to show significant cytotoxic activity against (inter alia) Lewis lung carcinoma, but its therapeutic use is largely limited due to an extremely short half-life in blood. This study aimed at developing a novel lipid nanocarrier-based formulation for lycobetaine delivery. The formulation is feasible for scale-up production, exhibiting goo...

2010
Sanyuan Hu Yangde Zhang

Endostar, a novel recombinant human endostatin, which was approved by the Chinese State Food and Drug Administration in 2005, has a broad spectrum of activity against solid tumors. In this study, we aimed to determine whether the anticancer effect of Endostar is increased by using a nanocarrier system. It is expected that the prolonged circulation of endostar will improve its anticancer activit...

2016
Heba Asem Ying Zhao Fei Ye Åsa Barrefelt Manuchehr Abedi-Valugerdi Ramy El-Sayed Ibrahim El-Serafi Khalid M Abu-Salah Jörg Hamm Mamoun Muhammed Moustapha Hassan

BACKGROUND Multifunctional nanocarriers for controlled drug delivery, imaging of disease development and follow-up of treatment efficacy are promising novel tools for disease diagnosis and treatment. In the current investigation, we present a multifunctional theranostic nanocarrier system for anticancer drug delivery and molecular imaging. Superparamagnetic iron oxide nanoparticles (SPIONs) as ...

2013
Chun Wu Faming Gong Pengfei Pang Min Shen Kangshun Zhu Du Cheng Zhihao Liu Hong Shan

RNA interference (RNAi) has significant therapeutic promise for the genetic treatment of hepatocellular carcinoma (HCC). Targeted vectors are able to deliver small interfering RNA (siRNA) into HCC cells with high transfection efficiency and stability. The tripeptide arginine glycine aspartic acid (RGD)-modified non-viral vector, polyethylene glycol-grafted polyethylenimine functionalized with s...

2015
Yijie Chen Xinran Wang Ting Liu Ding Sheng-zi Zhang Yunfei Wang Hongchen Gu Wen Di

Therapeutic antiangiogenesis strategies have demonstrated significant antitumor efficacy in ovarian cancer. Recently, RNA interference (RNAi) has come to be regarded as a promising technology for treatment of disease, especially cancer. In this study, vascular endothelial growth factor (VEGF)-small interfering RNA (siRNA) was encapsulated into a magnetic mesoporous silica nanoparticle (M-MSN)-b...

2014
Yingzhe Wang Wei Fan Xin Dai Usha Katragadda DeAngelo Mckinley Quincy Teng Chalet Tan

Gemcitabine is a potent anticancer drug approved for the treatment of pancreatic, non-small-cell lung, breast, and ovarian cancers. The major deficiencies of current gemcitabine therapy, however, are its rapid metabolic inactivation and narrow therapeutic window. Herein, we employed polyethylene glycol-b-distearoylphosphatidylethanolamine (PEG-DSPE)/tocopheryl polyethylene glycol 1000 succinate...

Journal: :Journal of controlled release : official journal of the Controlled Release Society 2018
Zhigao Niu Eleni Samaridou Emilie Jaumain Julie Coëne Gabriela Ullio Neha Shrestha Josep Garcia Matilde Durán-Lobato Sulay Tovar Manuel J Santander-Ortega M Victoria Lozano M Mar Arroyo-Jimenez Rocío Ramos-Membrive Iván Peñuelas Aloïse Mabondzo Véronique Préat Meritxell Teixidó Ernest Giralt María José Alonso

The objective of this work was the development of a new drug nanocarrier intended to overcome the barriers associated to the oral modality of administration and to assess its value for the systemic or local delivery of peptides. The nanocarrier was rationally designed taking into account the nature of the intestinal barriers and was loaded with insulin, which was selected as a model peptide. Th...

2018
Muyang Yang Lixia Yu Ruiwei Guo Anjie Dong Cunguo Lin Jianhua Zhang

Synergistic combination therapy by integrating chemotherapeutics and chemosensitizers into nanoparticles has demonstrated great potential to reduce side effects, overcome multidrug resistance (MDR), and thus improve therapeutic efficacy. However, with regard to the nanocarriers for multidrug codelivery, it remains a strong challenge to maintain design simplicity, while incorporating the desirab...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید